Pharmacological therapy in gestational diabetes – a comparison between insulin and oral therapy

References

• Jovanovic L, Pettitt DJ. Gestational diabetes mellitus. JAMA. 2001;286(20):2516–2518.
   PubMed Web of Science ®Google Scholar
• Sacks DA, Hadden D, Maresh M, et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care. 2012;35(3):526–528.
   PubMed Web of Science ®Google Scholar
• Feig DS, Hwee J, Shah BR, et al. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996–2010. Diabetes Care. 2014;37(6):1590–1596.
   PubMed Web of Science ®Google Scholar
• Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.
   PubMed Web of Science ®Google Scholar
• Mitanchez D. Foetal and neonatal complications in gestational diabetes: perinatal mortality, congenital malformations, macrosomia, shoulder dystocia, birth injuries, neonatal complications. Diabetes Metab. 2010;36(6 Pt 2):617–627.
   PubMed Web of Science ®Google Scholar
• Jensen DM, Damm P, Sørensen B, et al. Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol. 2001;185(2):413–419.
   PubMed Web of Science ®Google Scholar
• Jensen DM, Korsholm L, Ovesen P, et al. Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinical meaningful threshold value for glucose? Acta Obstet Gynecol Scand. 2008;87(1):59–62.
   PubMed Web of Science ®Google Scholar
• Ferrara A, Weiss NS, Hedderson MM, et al. Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the national diabetes data group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycemia and hyperbilirubinemia. Diabetologia. 2007;50(2):298–306.
   PubMed Web of Science ®Google Scholar
• Sermer M, Naylor CD, Gare DJ, et al. Impact of increasing carbohydrate intolerance on maternal–fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol. 1995;173(1):146–156.
   PubMed Web of Science ®Google Scholar
• Mukerji G, Feig DS. Pharmacological management of gestational diabetes mellitus. Drugs. 2017;77(16):1723–1732.
   PubMed Web of Science ®Google Scholar
• Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339–1348.
   PubMed Web of Science ®Google Scholar
• Crowther CA, Hiller JE, Moss JR, et al. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–2486.
   PubMed Web of Science ®Google Scholar
• Hartling L, Dryden DM, Guthrie A, et al. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med. 2013;159(2):123–129.
   PubMed Web of Science ®Google Scholar
• Lv S, Wang J, Xu Y. Safety of insulin analogs during pregnancy: a meta-analysis. Arch Gynecol Obstet. 2015;292(4):749–756.
   PubMed Web of Science ®Google Scholar
• Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358(19):2003–2015.
   PubMed Web of Science ®Google Scholar
• Balsells M, García-Patterson A, Solà I, et al. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ. 2015;350:h102.
   PubMed Web of Science ®Google Scholar
• Langer O, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343(16):1134–1138.
   PubMed Web of Science ®Google Scholar
• Song R, Chen L, Chen Y, et al. Comparison of glyburide and insulin in the management of gestational diabetes: a meta-analysis. PLOS One. 2017;12(8):e0182488.
   PubMed Web of Science ®Google Scholar
• Committee on Practice Bulletins – Obstetrics. ACOG Practice Bulletin No. 190: gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):e49–e64.
   PubMedGoogle Scholar
• American Diabetes Association. Management of diabetes in pregnancy. Diabetes Care. 2017;40(Suppl. 1):S114–S119.
   PubMedGoogle Scholar
• Thompson D, Berger H, Feig D, et al. Diabetes and pregnancy. Can J Diabetes. 2013;37(Suppl. 1):S168–S183.
   PubMedGoogle Scholar
• Diabetes in pregnancy: management from preconception to the postnatal period. London: National Institute for Health and Care Excellence; 2015; [cited 2015 Feb 25]. Available from: nice.org.uk/guidance/ng3
   Google Scholar
• Camelo Castillo W, Boggess K, Stürmer T, et al. Trend in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000–2011. Obstet Gynecol. 2014;123(6):1177–1184.
   PubMed Web of Science ®Google Scholar
• Chmait R, Dinise T, Moore T. Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. J Perinatol. 2004;24(10):617–622.
   PubMedGoogle Scholar
• Goetzl L, Wilkins I. Glyburide compared to insulin for the treatment of gestational diabetes mellitus: a cost analysis. J Perinatol. 2002;22(5):403–406.
   PubMedGoogle Scholar
• Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768–773.
   PubMed Web of Science ®Google Scholar
• Dollberg S, Haklai Z, Mimouni FB, et al. Birth weight standards in the live-born population in Israel. Isr Med Assoc J. 2005;7(5):311–314.
   PubMed Web of Science ®Google Scholar
• Ramos GA, Jacobson GF, Kirby RS, et al. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia. J Perinatol. 2007;27(5):262–267.
   PubMed Web of Science ®Google Scholar
• Lain KY, Garabedian MJ, Daftary A, et al. Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared with insulin. Am J Obstet Gynecol. 2009;200(5):501.e1–501.e6.
   PubMed Web of Science ®Google Scholar
• Zeng YC, Li MJ, Chen Y, et al. The use of glyburide in the management of gestational diabetes mellitus: a meta-analysis. Adv Med Sci. 2014;59(1):95–101.
   PubMed Web of Science ®Google Scholar
• Jacobson GF, Ramos GA, Ching JY, et al. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol. 2005;193(1):118–124.
   PubMed Web of Science ®Google Scholar
• Kahn BF, Davies JK, Lynch AM, et al. Predictors of glyburide failure in the treatment of gestational diabetes. Obstet Gynecol. 2006;107(6):1303–1309.
   PubMed Web of Science ®Google Scholar
• Kremer CJ, Duff P. Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol. 2004;190(5):1438–1439.
   PubMed Web of Science ®Google Scholar
• Sénat MV, Affres H, Letourneau A, et al. Groupe de Recherche en Obstétrique et Gynécologie (GROG). Effect of glyburide vs subcutaneous insulin on perinatal complications among women with gestational diabetes: a randomized clinical trial. Obstet Gynecol Surv. 2018;73(9):511–513.
   Web of Science ®Google Scholar
• Tempe A, Mayanglambam RD. Glyburide as treatment option for gestational diabetes mellitus. J Obstet Gynaecol Res. 2013;39(6):1147–1152.
   PubMed Web of Science ®Google Scholar
• Anjalakshi C, Balaji V, Balaji MS, et al. A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women. Diabetes Res Clin Pract. 2007;76(3):474–475.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay P, Bag T, Kyal A, et al. Oral hypoglycemic glibenclamide: can it be a substitute to insulin in the management of gestational diabetes mellitus? A comparative study. J SAFOG. 2012;4(1):28–31.
   Google Scholar
• Diaz P, Dimasuay KG, Koele-Schmidt L, et al. Glyburide treatment in gestational diabetes is associated with increased placental glucose transporter 1 expression and higher birth weight. Placenta. 2017;57:52–59.
   PubMed Web of Science ®Google Scholar
• Caritis SN, Hebert MF. A pharmacologic approach to the use of glyburide in pregnancy. Obstet Gynecol. 2013;121(6):1309–1312.
   PubMed Web of Science ®Google Scholar